APPLIED GENETIC TECHNOLOGIES CORP Deferred Tax Assets, Net of Valuation Allowance
APPLIED GENETIC TECHNOLOGIES CORP had Deferred Tax Assets, Net of Valuation Allowance of $959.00 thousand as of 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2022-09-27
- 2022-06-30: Deferred Tax Assets, Net of Valuation Allowance $959.00K.
- 2021-06-30: Deferred Tax Assets, Net of Valuation Allowance $1.05M.
- 2020-06-30: Deferred Tax Assets, Net of Valuation Allowance $877.00K.
- 2017-06-30: Deferred Tax Assets, Net of Valuation Allowance $3.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2022-06-30 | $959.00K 10-K · filed 2022-09-27 |
| 2021-06-30 | $1.05M 10-K · filed 2022-09-27 |
| 2020-06-30 | $877.00K 10-K · filed 2021-09-23 |
| 2017-06-30 | $3.00K 10-K · filed 2018-09-11 |
| 2016-06-30 | $61.00K 10-K · filed 2017-09-13 |
| 2015-06-30 | $73.00K 10-K/A · filed 2017-09-08 |
| 2014-06-30 | $75.00K 10-K · filed 2015-09-10 |
| 2013-06-30 | $84.00K 10-K · filed 2014-09-26 |